Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

NASDAQLPCN
FormDescriptionDateFormat
S-1/AAmended Registration statement for face-amount certificate companiesFeb 10, 2012Open Amended Registration statement for face-amount certificate companies in HTML.Open Amended Registration statement for face-amount certificate companies in DOC file.Open Amended Registration statement for face-amount certificate companies in PDF file.Open Amended Registration statement for face-amount certificate companies in XLS file.
S-1/AAmended Registration statement for face-amount certificate companiesFeb 1, 2012Open Amended Registration statement for face-amount certificate companies in HTML.Open Amended Registration statement for face-amount certificate companies in DOC file.Open Amended Registration statement for face-amount certificate companies in PDF file.Open Amended Registration statement for face-amount certificate companies in XLS file.
S-1/AAmended Registration statement for face-amount certificate companiesJan 23, 2012Open Amended Registration statement for face-amount certificate companies in HTML.Open Amended Registration statement for face-amount certificate companies in DOC file.Open Amended Registration statement for face-amount certificate companies in PDF file.Open Amended Registration statement for face-amount certificate companies in XLS file.
S-1/AAmended Registration statement for face-amount certificate companiesJan 13, 2012Open Amended Registration statement for face-amount certificate companies in HTML.Open Amended Registration statement for face-amount certificate companies in DOC file.Open Amended Registration statement for face-amount certificate companies in PDF file.Open Amended Registration statement for face-amount certificate companies in XLS file.